世界の組織球症治療市場2023年:企業・地域・タイプ・用途別分析

【英語タイトル】Global Histiocytosis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料(GIR23AG11559)・商品コード:GIR23AG11559
・発行会社(調査会社):GlobalInfoResearch
・発行日:2023年8月
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(注文後2-3日)
・調査対象地域:グローバル
・産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の組織球症治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の組織球症治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 組織球症治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

組織球症治療市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・経口式、注射式

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・SOBI、AB2 Bio Ltd.、Alpine Immune Sciencs、Bellicum Pharmaceuticals、Sanofi、Pfizer Inc.、Johnson & Johnson Services、Incyte corporation、Symbiotec、Curia、Merck、Teva、Mylan、Apotex、Novartis、Eli Lilly、Amgen、Tecoland

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、組織球症治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な組織球症治療メーカーの企業概要、2019年~2022年までの組織球症治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な組織球症治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別組織球症治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの組織球症治療のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での組織球症治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および組織球症治療の産業チェーンを掲載しています。
・第14、15章では、組織球症治療の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 組織球症治療の概要
– タイプ別分析(2018年vs2022年vs2029年):経口式、注射式
– 用途別分析(2018年vs2022年vs2029年):病院薬局、小売薬局、オンライン薬局
– 世界の組織球症治療市場規模・予測
– 世界の組織球症治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– SOBI、AB2 Bio Ltd.、Alpine Immune Sciencs、Bellicum Pharmaceuticals、Sanofi、Pfizer Inc.、Johnson & Johnson Services、Incyte corporation、Symbiotec、Curia、Merck、Teva、Mylan、Apotex、Novartis、Eli Lilly、Amgen、Tecoland
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:経口式、注射式
・用途別分析2018年-2029年:病院薬局、小売薬局、オンライン薬局
・組織球症治療の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・組織球症治療のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・組織球症治療のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・組織球症治療の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・組織球症治療の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Histiocytosis Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Histiocytosis Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Histiocytosis Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Histiocytosis Treatment Market Size & Forecast
1.5.1 Global Histiocytosis Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Histiocytosis Treatment Sales Quantity (2018-2029)
1.5.3 Global Histiocytosis Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 SOBI
2.1.1 SOBI Details
2.1.2 SOBI Major Business
2.1.3 SOBI Histiocytosis Treatment Product and Services
2.1.4 SOBI Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 SOBI Recent Developments/Updates
2.2 AB2 Bio Ltd.
2.2.1 AB2 Bio Ltd. Details
2.2.2 AB2 Bio Ltd. Major Business
2.2.3 AB2 Bio Ltd. Histiocytosis Treatment Product and Services
2.2.4 AB2 Bio Ltd. Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AB2 Bio Ltd. Recent Developments/Updates
2.3 Alpine Immune Sciencs
2.3.1 Alpine Immune Sciencs Details
2.3.2 Alpine Immune Sciencs Major Business
2.3.3 Alpine Immune Sciencs Histiocytosis Treatment Product and Services
2.3.4 Alpine Immune Sciencs Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Alpine Immune Sciencs Recent Developments/Updates
2.4 Bellicum Pharmaceuticals
2.4.1 Bellicum Pharmaceuticals Details
2.4.2 Bellicum Pharmaceuticals Major Business
2.4.3 Bellicum Pharmaceuticals Histiocytosis Treatment Product and Services
2.4.4 Bellicum Pharmaceuticals Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bellicum Pharmaceuticals Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Histiocytosis Treatment Product and Services
2.5.4 Sanofi Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Histiocytosis Treatment Product and Services
2.6.4 Pfizer Inc. Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Inc. Recent Developments/Updates
2.7 Johnson & Johnson Services
2.7.1 Johnson & Johnson Services Details
2.7.2 Johnson & Johnson Services Major Business
2.7.3 Johnson & Johnson Services Histiocytosis Treatment Product and Services
2.7.4 Johnson & Johnson Services Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Services Recent Developments/Updates
2.8 Incyte corporation
2.8.1 Incyte corporation Details
2.8.2 Incyte corporation Major Business
2.8.3 Incyte corporation Histiocytosis Treatment Product and Services
2.8.4 Incyte corporation Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Incyte corporation Recent Developments/Updates
2.9 Symbiotec
2.9.1 Symbiotec Details
2.9.2 Symbiotec Major Business
2.9.3 Symbiotec Histiocytosis Treatment Product and Services
2.9.4 Symbiotec Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Symbiotec Recent Developments/Updates
2.10 Curia
2.10.1 Curia Details
2.10.2 Curia Major Business
2.10.3 Curia Histiocytosis Treatment Product and Services
2.10.4 Curia Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Curia Recent Developments/Updates
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Histiocytosis Treatment Product and Services
2.11.4 Merck Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck Recent Developments/Updates
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Histiocytosis Treatment Product and Services
2.12.4 Teva Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Teva Recent Developments/Updates
2.13 Mylan
2.13.1 Mylan Details
2.13.2 Mylan Major Business
2.13.3 Mylan Histiocytosis Treatment Product and Services
2.13.4 Mylan Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Mylan Recent Developments/Updates
2.14 Apotex
2.14.1 Apotex Details
2.14.2 Apotex Major Business
2.14.3 Apotex Histiocytosis Treatment Product and Services
2.14.4 Apotex Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Apotex Recent Developments/Updates
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Histiocytosis Treatment Product and Services
2.15.4 Novartis Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Novartis Recent Developments/Updates
2.16 Eli Lilly
2.16.1 Eli Lilly Details
2.16.2 Eli Lilly Major Business
2.16.3 Eli Lilly Histiocytosis Treatment Product and Services
2.16.4 Eli Lilly Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Eli Lilly Recent Developments/Updates
2.17 Amgen
2.17.1 Amgen Details
2.17.2 Amgen Major Business
2.17.3 Amgen Histiocytosis Treatment Product and Services
2.17.4 Amgen Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Amgen Recent Developments/Updates
2.18 Tecoland
2.18.1 Tecoland Details
2.18.2 Tecoland Major Business
2.18.3 Tecoland Histiocytosis Treatment Product and Services
2.18.4 Tecoland Histiocytosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Tecoland Recent Developments/Updates
3 Competitive Environment: Histiocytosis Treatment by Manufacturer
3.1 Global Histiocytosis Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Histiocytosis Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Histiocytosis Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Histiocytosis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Histiocytosis Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Histiocytosis Treatment Manufacturer Market Share in 2022
3.5 Histiocytosis Treatment Market: Overall Company Footprint Analysis
3.5.1 Histiocytosis Treatment Market: Region Footprint
3.5.2 Histiocytosis Treatment Market: Company Product Type Footprint
3.5.3 Histiocytosis Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Histiocytosis Treatment Market Size by Region
4.1.1 Global Histiocytosis Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Histiocytosis Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Histiocytosis Treatment Average Price by Region (2018-2029)
4.2 North America Histiocytosis Treatment Consumption Value (2018-2029)
4.3 Europe Histiocytosis Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Histiocytosis Treatment Consumption Value (2018-2029)
4.5 South America Histiocytosis Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Histiocytosis Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Histiocytosis Treatment Sales Quantity by Type (2018-2029)
5.2 Global Histiocytosis Treatment Consumption Value by Type (2018-2029)
5.3 Global Histiocytosis Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Histiocytosis Treatment Sales Quantity by Application (2018-2029)
6.2 Global Histiocytosis Treatment Consumption Value by Application (2018-2029)
6.3 Global Histiocytosis Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Histiocytosis Treatment Sales Quantity by Type (2018-2029)
7.2 North America Histiocytosis Treatment Sales Quantity by Application (2018-2029)
7.3 North America Histiocytosis Treatment Market Size by Country
7.3.1 North America Histiocytosis Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Histiocytosis Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Histiocytosis Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Histiocytosis Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Histiocytosis Treatment Market Size by Country
8.3.1 Europe Histiocytosis Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Histiocytosis Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Histiocytosis Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Histiocytosis Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Histiocytosis Treatment Market Size by Region
9.3.1 Asia-Pacific Histiocytosis Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Histiocytosis Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Histiocytosis Treatment Sales Quantity by Type (2018-2029)
10.2 South America Histiocytosis Treatment Sales Quantity by Application (2018-2029)
10.3 South America Histiocytosis Treatment Market Size by Country
10.3.1 South America Histiocytosis Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Histiocytosis Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Histiocytosis Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Histiocytosis Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Histiocytosis Treatment Market Size by Country
11.3.1 Middle East & Africa Histiocytosis Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Histiocytosis Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Histiocytosis Treatment Market Drivers
12.2 Histiocytosis Treatment Market Restraints
12.3 Histiocytosis Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Histiocytosis Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Histiocytosis Treatment
13.3 Histiocytosis Treatment Production Process
13.4 Histiocytosis Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Histiocytosis Treatment Typical Distributors
14.3 Histiocytosis Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Histiocytosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Histiocytosis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. SOBI Basic Information, Manufacturing Base and Competitors
Table 4. SOBI Major Business
Table 5. SOBI Histiocytosis Treatment Product and Services
Table 6. SOBI Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. SOBI Recent Developments/Updates
Table 8. AB2 Bio Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. AB2 Bio Ltd. Major Business
Table 10. AB2 Bio Ltd. Histiocytosis Treatment Product and Services
Table 11. AB2 Bio Ltd. Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AB2 Bio Ltd. Recent Developments/Updates
Table 13. Alpine Immune Sciencs Basic Information, Manufacturing Base and Competitors
Table 14. Alpine Immune Sciencs Major Business
Table 15. Alpine Immune Sciencs Histiocytosis Treatment Product and Services
Table 16. Alpine Immune Sciencs Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Alpine Immune Sciencs Recent Developments/Updates
Table 18. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Bellicum Pharmaceuticals Major Business
Table 20. Bellicum Pharmaceuticals Histiocytosis Treatment Product and Services
Table 21. Bellicum Pharmaceuticals Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bellicum Pharmaceuticals Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Histiocytosis Treatment Product and Services
Table 26. Sanofi Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Recent Developments/Updates
Table 28. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Inc. Major Business
Table 30. Pfizer Inc. Histiocytosis Treatment Product and Services
Table 31. Pfizer Inc. Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Inc. Recent Developments/Updates
Table 33. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Services Major Business
Table 35. Johnson & Johnson Services Histiocytosis Treatment Product and Services
Table 36. Johnson & Johnson Services Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Johnson & Johnson Services Recent Developments/Updates
Table 38. Incyte corporation Basic Information, Manufacturing Base and Competitors
Table 39. Incyte corporation Major Business
Table 40. Incyte corporation Histiocytosis Treatment Product and Services
Table 41. Incyte corporation Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Incyte corporation Recent Developments/Updates
Table 43. Symbiotec Basic Information, Manufacturing Base and Competitors
Table 44. Symbiotec Major Business
Table 45. Symbiotec Histiocytosis Treatment Product and Services
Table 46. Symbiotec Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Symbiotec Recent Developments/Updates
Table 48. Curia Basic Information, Manufacturing Base and Competitors
Table 49. Curia Major Business
Table 50. Curia Histiocytosis Treatment Product and Services
Table 51. Curia Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Curia Recent Developments/Updates
Table 53. Merck Basic Information, Manufacturing Base and Competitors
Table 54. Merck Major Business
Table 55. Merck Histiocytosis Treatment Product and Services
Table 56. Merck Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Merck Recent Developments/Updates
Table 58. Teva Basic Information, Manufacturing Base and Competitors
Table 59. Teva Major Business
Table 60. Teva Histiocytosis Treatment Product and Services
Table 61. Teva Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Teva Recent Developments/Updates
Table 63. Mylan Basic Information, Manufacturing Base and Competitors
Table 64. Mylan Major Business
Table 65. Mylan Histiocytosis Treatment Product and Services
Table 66. Mylan Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Mylan Recent Developments/Updates
Table 68. Apotex Basic Information, Manufacturing Base and Competitors
Table 69. Apotex Major Business
Table 70. Apotex Histiocytosis Treatment Product and Services
Table 71. Apotex Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Apotex Recent Developments/Updates
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Histiocytosis Treatment Product and Services
Table 76. Novartis Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 79. Eli Lilly Major Business
Table 80. Eli Lilly Histiocytosis Treatment Product and Services
Table 81. Eli Lilly Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Eli Lilly Recent Developments/Updates
Table 83. Amgen Basic Information, Manufacturing Base and Competitors
Table 84. Amgen Major Business
Table 85. Amgen Histiocytosis Treatment Product and Services
Table 86. Amgen Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Amgen Recent Developments/Updates
Table 88. Tecoland Basic Information, Manufacturing Base and Competitors
Table 89. Tecoland Major Business
Table 90. Tecoland Histiocytosis Treatment Product and Services
Table 91. Tecoland Histiocytosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Tecoland Recent Developments/Updates
Table 93. Global Histiocytosis Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Histiocytosis Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Histiocytosis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 96. Market Position of Manufacturers in Histiocytosis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Histiocytosis Treatment Production Site of Key Manufacturer
Table 98. Histiocytosis Treatment Market: Company Product Type Footprint
Table 99. Histiocytosis Treatment Market: Company Product Application Footprint
Table 100. Histiocytosis Treatment New Market Entrants and Barriers to Market Entry
Table 101. Histiocytosis Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Histiocytosis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Histiocytosis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Histiocytosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Histiocytosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Histiocytosis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 107. Global Histiocytosis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 108. Global Histiocytosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Histiocytosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Histiocytosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Histiocytosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Histiocytosis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 113. Global Histiocytosis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 114. Global Histiocytosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Histiocytosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Histiocytosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Histiocytosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Histiocytosis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 119. Global Histiocytosis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 120. North America Histiocytosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Histiocytosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Histiocytosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Histiocytosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Histiocytosis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Histiocytosis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Histiocytosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Histiocytosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Histiocytosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Histiocytosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Histiocytosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Histiocytosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Histiocytosis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Histiocytosis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Histiocytosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Histiocytosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Histiocytosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Histiocytosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Histiocytosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Histiocytosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Histiocytosis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Histiocytosis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Histiocytosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Histiocytosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Histiocytosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Histiocytosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Histiocytosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Histiocytosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Histiocytosis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Histiocytosis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Histiocytosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Histiocytosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Histiocytosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Histiocytosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Histiocytosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Histiocytosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Histiocytosis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Histiocytosis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Histiocytosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Histiocytosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Histiocytosis Treatment Raw Material
Table 161. Key Manufacturers of Histiocytosis Treatment Raw Materials
Table 162. Histiocytosis Treatment Typical Distributors
Table 163. Histiocytosis Treatment Typical Customers
List of Figures
Figure 1. Histiocytosis Treatment Picture
Figure 2. Global Histiocytosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Histiocytosis Treatment Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Injection Examples
Figure 6. Global Histiocytosis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Histiocytosis Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Histiocytosis Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Histiocytosis Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Histiocytosis Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Histiocytosis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Histiocytosis Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Histiocytosis Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Histiocytosis Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Histiocytosis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Histiocytosis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Histiocytosis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Histiocytosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Histiocytosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Histiocytosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Histiocytosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Histiocytosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Histiocytosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Histiocytosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Histiocytosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Histiocytosis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Histiocytosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Histiocytosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Histiocytosis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Histiocytosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Histiocytosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Histiocytosis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Histiocytosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Histiocytosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Histiocytosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Histiocytosis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Histiocytosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Histiocytosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Histiocytosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Histiocytosis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Histiocytosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Histiocytosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Histiocytosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Histiocytosis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Histiocytosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Histiocytosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Histiocytosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Histiocytosis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Histiocytosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Histiocytosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Histiocytosis Treatment Market Drivers
Figure 74. Histiocytosis Treatment Market Restraints
Figure 75. Histiocytosis Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Histiocytosis Treatment in 2022
Figure 78. Manufacturing Process Analysis of Histiocytosis Treatment
Figure 79. Histiocytosis Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


★調査レポート[世界の組織球症治療市場2023年:企業・地域・タイプ・用途別分析] (コード:GIR23AG11559)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組織球症治療市場2023年:企業・地域・タイプ・用途別分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆